| Date Initiated by Firm | December 07, 2017 |
| Date Posted | September 27, 2019 |
| Recall Status1 |
Terminated 3 on June 09, 2020 |
| Recall Number | Z-2761-2019 |
| Recall Event ID |
83629 |
| Product Classification |
Activated partial thromboplastin - Product Code GFO
|
| Product | Cascade Abrazo aPTT Test Card, Model 5722, For Export Only. The firm name on the label is Helena Laboratories, Beaumont, TX. |
| Code Information |
Lot number 2-17-5722, Exp. 2018-09-30 |
| FEI Number |
1618982
|
Recalling Firm/ Manufacturer |
Helena Laboratories, Corp.
1530 Lindbergh Dr
Beaumont
TX
77707-4131
|
| For Additional Information Contact | Dr. Jessica Jones Hanka 409-842-3714 |
Manufacturer Reason for Recall | Some of the cards show occasional shorter clot times than the expected variation resulting in a potential false negative result on the screening assay. |
FDA Determined Cause 2 | Unknown/Undetermined by firm |
| Action | The recalling firm issued letters dated 11/12/2017 via email on 12/7/2017 explaining the issue and that they were doing a withdrawal of the lot. |
| Quantity in Commerce | 21 kits |
| Distribution | Distribution was made to Germany and Australia. There was no U.S. distribution. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
|